Wang, C., Li, X., Zhang, J., Ge, Z., Chen, H., & Hu, J. (2018). EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression. Onco Targets Ther.
Chicago Style CitationWang, Chenyu, Xingwang Li, Junjie Zhang, Zheng Ge, Hejin Chen, i Junhong Hu. "EZH2 Contributes to 5-FU Resistance in Gastric Cancer By Epigenetically Suppressing FBXO32 Expression." Onco Targets Ther 2018.
Cita MLAWang, Chenyu, et al. "EZH2 Contributes to 5-FU Resistance in Gastric Cancer By Epigenetically Suppressing FBXO32 Expression." Onco Targets Ther 2018.
Atenció: Aquestes cites poden no estar 100% correctes.